TRICOP – A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD
Katharina Marth, Andreas Renner, Wolfgang Pohl
Topics & Concepts
MedicineTolerabilityExacerbationCOPDInhalerInternal medicineAdverse effectFormoterolPhysical therapyAsthmaBudesonideChronic Obstructive Pulmonary Disease (COPD) ResearchInhalation and Respiratory Drug DeliveryRespiratory and Cough-Related Research